200 related articles for article (PubMed ID: 29128178)
21. Cost-effectiveness of FDG-PET/CT for cytologically indeterminate thyroid nodules: a decision analytic approach.
Vriens D; Adang EM; Netea-Maier RT; Smit JW; de Wilt JH; Oyen WJ; de Geus-Oei LF
J Clin Endocrinol Metab; 2014 Sep; 99(9):3263-74. PubMed ID: 24873995
[TBL] [Abstract][Full Text] [Related]
22. Molecular testing for indeterminate thyroid nodules: Performance of the Afirma gene expression classifier and ThyroSeq panel.
Jug RC; Datto MB; Jiang XS
Cancer Cytopathol; 2018 Jul; 126(7):471-480. PubMed ID: 29637728
[TBL] [Abstract][Full Text] [Related]
23. Is Less More? A Microsimulation Model Comparing Cost-effectiveness of the Revised American Thyroid Association's 2015 to 2009 Guidelines for the Management of Patients With Thyroid Nodules and Differentiated Thyroid Cancer.
White C; Weinstein MC; Fingeret AL; Randolph GW; Miyauchi A; Ito Y; Zhan T; Ali A; Gazelle GS; Lubitz CC
Ann Surg; 2020 Apr; 271(4):765-773. PubMed ID: 30339630
[TBL] [Abstract][Full Text] [Related]
24. Relationship Between Sonographic Characteristics and Afirma Gene Expression Classifier Results in Thyroid Nodules With Indeterminate Fine-Needle Aspiration Cytopathology.
Zhu QL; Faquin WC; Samir AE
AJR Am J Roentgenol; 2015 Oct; 205(4):861-5. PubMed ID: 26397337
[TBL] [Abstract][Full Text] [Related]
25. Features of Cytologically Indeterminate Molecularly Benign Nodules Treated With Surgery.
Endo M; Porter K; Long C; Azaryan I; Phay JE; Ringel MD; Sipos JA; Nabhan F
J Clin Endocrinol Metab; 2020 Nov; 105(11):e3971-80. PubMed ID: 32772084
[TBL] [Abstract][Full Text] [Related]
26. Noninvasive Follicular Variant of Papillary Thyroid Carcinoma and the Afirma Gene-Expression Classifier.
Wong KS; Angell TE; Strickland KC; Alexander EK; Cibas ES; Krane JF; Barletta JA
Thyroid; 2016 Jul; 26(7):911-5. PubMed ID: 27219469
[TBL] [Abstract][Full Text] [Related]
27. How "suspicious" is that nodule? Review of "suspicious" Afirma gene expression classifier in high risk thyroid nodules.
Roychoudhury S; Klein M; Souza F; Gimenez C; Laser A; Shaheen Cocker R; Chau K; Das K
Diagn Cytopathol; 2017 Apr; 45(4):308-311. PubMed ID: 28188700
[TBL] [Abstract][Full Text] [Related]
28. Long-Term Outcomes of Thyroid Nodule AFIRMA GEC Testing and Literature Review: An Institutional Experience.
Vora A; Holt S; Haque W; Lingvay I
Otolaryngol Head Neck Surg; 2020 May; 162(5):634-640. PubMed ID: 32182188
[TBL] [Abstract][Full Text] [Related]
29. Effect of malignancy rates on cost-effectiveness of routine gene expression classifier testing for indeterminate thyroid nodules.
Wu JX; Lam R; Levin M; Rao J; Sullivan PS; Yeh MW
Surgery; 2016 Jan; 159(1):118-26. PubMed ID: 26435428
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the Afirma Gene Expression Classifier in Repeat Indeterminate Thyroid Nodules.
Harrison G; Sosa JA; Jiang X
Arch Pathol Lab Med; 2017 Jul; 141(7):985-989. PubMed ID: 28467214
[TBL] [Abstract][Full Text] [Related]
31. Cost analysis of thyroid lobectomy and intraoperative frozen section versus total thyroidectomy in patients with a cytologic diagnosis of "suspicious for papillary thyroid cancer".
Leiker AJ; Yen TW; Cheung K; Evans DB; Wang TS
Surgery; 2013 Dec; 154(6):1307-13; discussion 1313-4. PubMed ID: 24238049
[TBL] [Abstract][Full Text] [Related]
32. The association between the ultrasonography TIRADS classification system and surgical pathology among indeterminate thyroid nodules.
Sahli ZT; Karipineni F; Hang JF; Canner JK; Mathur A; Prescott JD; Sheth S; Ali SZ; Zeiger MA
Surgery; 2019 Jan; 165(1):69-74. PubMed ID: 30415866
[TBL] [Abstract][Full Text] [Related]
33. TIRADS Interobserver Variability Among Indeterminate Thyroid Nodules: A Single-Institution Study.
Sahli ZT; Sharma AK; Canner JK; Karipineni F; Ali O; Kawamoto S; Hang JF; Mathur A; Ali SZ; Zeiger MA; Sheth S
J Ultrasound Med; 2019 Jul; 38(7):1807-1813. PubMed ID: 30467876
[TBL] [Abstract][Full Text] [Related]
34. If the price is right: Cost-effectiveness of radiofrequency ablation versus thyroidectomy in the treatment of benign thyroid nodules.
Kuo EJ; Oh A; Hu Y; McManus CM; Lee JA; Kuo JH
Surgery; 2023 Jan; 173(1):201-206. PubMed ID: 36334980
[TBL] [Abstract][Full Text] [Related]
35. Clinical diagnostic gene expression thyroid testing.
Steward DL; Kloos RT
Otolaryngol Clin North Am; 2014 Aug; 47(4):573-93. PubMed ID: 25041959
[TBL] [Abstract][Full Text] [Related]
36. Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes.
Baca SC; Wong KS; Strickland KC; Heller HT; Kim MI; Barletta JA; Cibas ES; Krane JF; Marqusee E; Angell TE
Cancer Cytopathol; 2017 May; 125(5):313-322. PubMed ID: 28152275
[TBL] [Abstract][Full Text] [Related]
37. Utility of Intraoperative Frozen Section in Large Thyroid Nodules.
Bollig CA; Jorgensen JB; Zitsch RP; Dooley LM
Otolaryngol Head Neck Surg; 2019 Jan; 160(1):49-56. PubMed ID: 30322356
[TBL] [Abstract][Full Text] [Related]
38. Molecular Diagnostic Evaluation of Thyroid Nodules.
Mayson SE; Haugen BR
Endocrinol Metab Clin North Am; 2019 Mar; 48(1):85-97. PubMed ID: 30717912
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness of active surveillance versus hemithyroidectomy for micropapillary thyroid cancer.
Venkatesh S; Pasternak JD; Beninato T; Drake FT; Kluijfhout WP; Liu C; Gosnell JE; Shen WT; Clark OH; Duh QY; Suh I
Surgery; 2017 Jan; 161(1):116-126. PubMed ID: 27839930
[TBL] [Abstract][Full Text] [Related]
40. A cost-effectiveness comparison between early surgery and non-surgical approach for incidental papillary thyroid microcarcinoma.
Lang BH; Wong CK
Eur J Endocrinol; 2015 Sep; 173(3):367-75. PubMed ID: 26104754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
